{
  "report_rows": [
    {
      "kpi": "Normalized FFO per share (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$0.98 vs. cons $0.96",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Total Revenue (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$1.71B vs. cons $1.67B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Resident Fees and Services Revenue / SHOP momentum proxy (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$1.32B vs. cons $1.29B",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 Normalized FFO per share guidance",
      "prediction": "BETTER",
      "answer": "guide ~$3.92-3.96 (midpoint ~$3.94) vs. cons $3.86 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 SHOP Same-Store Cash NOI growth guidance",
      "prediction": "BETTER",
      "answer": "guide ~17-18% vs. cons/prior guide 16% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 Investment volume guidance",
      "prediction": "BETTER",
      "answer": "guide ~$3.5B vs. cons/prior guide $3.0B (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": -2.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -3.5,
  "day5_path": "FADE",
  "day5_rationale": "Stock has rallied ~27% YTD and +16% in the month into the print, with a beat-and-modest-raise already the base case after Welltower's blowout Q2 (25% FFO growth, SHOP NOI +20.5%, guide raised to 18.5-21.5%) reset sector expectations higher just one day prior. Even if VTR posts a solid beat (~2% on FFO/revenue) and raises FY26 FFO/SHOP NOI/investment guidance modestly, the magnitude is unlikely to match Welltower's step-change, so the incremental raise is largely 'in the price' and implies the back-half run-rate needed to hit even the new guide is only slightly above current Street math - a classic 'sell-the-news' setup. Initial day-1 dip from profit-taking should be followed by continued mild fade over the week as analysts true up 2H estimates modestly higher but valuation (still trading near all-time highs, ~18% above some DCF fair-value checks flagged by SWS) compresses, rather than a durable follow-through re-rating.",
  "day5_confidence": "MEDIUM"
}